Patents by Inventor Amalendu Prakash Ranjan

Amalendu Prakash Ranjan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR ENGINEERING TARGETED NANOPARTICLES
    Publication number: 20220008350
    Abstract: Certain embodiments are directed to methods for making programmable bioinspired nanoparticles (P-BiNP). Nanoparticles are coated with a cell membrane derived from a cell stimulated to express or overexpress a protein identified as being expressed in a target cell, forming a homotypic and organ targeted nanoparticle delivery vehicle.
    Type: Application
    Filed: October 16, 2019
    Publication date: January 13, 2022
    Applicant: University of North Texas Health Science Center
    Inventors: Jamboor K. VISHWANATHA, Andrew GDOWSKI, Amalendu Prakash RANJAN, Anindita MUKERJEE
  • Curcumin-ER, a liposomal-PLGA sustained release nanocurcumin for minimizing QT prolongation for cancer therapy
    Patent number: 9138411
    Abstract: The present invention includes compositions and methods of making a nanoparticle composition comprising a polymeric core comprising one or more polymers and one or more active agents, and at least one layer of one or more lipids on the surface of the polymeric core; more specifically, the invention relates to the use of curcumin within such a lipid-polymer nanoparticle formulation for minimizing QT prolongation associated with curcumin in treatment of cancer.
    Type: Grant
    Filed: August 31, 2013
    Date of Patent: September 22, 2015
    Assignees: University of North Texas Health Science Center at Fort Worth, SignPath Pharma, Inc.
    Inventors: Amalendu Prakash Ranjan, Anindita Mukerjee, Jamboor K. Vishwanatha, Lawrence Helson
  • CURCUMIN-ER, A LIPOSOMAL-PLGA SUSTAINED RELEASE NANOCURCUMIN FOR MINIMIZING QT PROLONGATION FOR CANCER THERAPY
    Publication number: 20150258026
    Abstract: The present invention includes compositions and methods of making a nanoparticle composition comprising a polymeric core comprising one or more polymers and one or more active agents, and at least one layer of one or more lipids on the surface of the polymeric core; more specifically, the invention relates to the use of curcumin within such a lipid-polymer nanoparticle formulation for minimizing QT prolongation associated with curcumin in treatment of cancer.
    Type: Application
    Filed: May 29, 2015
    Publication date: September 17, 2015
    Inventors: Amalendu Prakash Ranjan, Anindita Mukerjee, Jamboor K. Vishwanatha, Lawrence Helson
  • CURCUMIN-ER, A LIPOSOMAL-PLGA SUSTAINED RELEASE NANOCURCUMIN FOR MINIMIZING QT PROLONGATION FOR CANCER THERAPY
    Publication number: 20140065061
    Abstract: The present invention includes compositions and methods of making a nanoparticle composition comprising a polymeric core comprising one or more polymers and one or more active agents, and at least one layer of one or more lipids on the surface of the polymeric core; more specifically, the invention relates to the use of curcumin within such a lipid-polymer nanoparticle formulation for minimizing QT prolongation associated with curcumin in treatment of cancer.
    Type: Application
    Filed: August 31, 2013
    Publication date: March 6, 2014
    Applicants: SignPath Pharma Inc., University of North Texas Health Science Center
    Inventors: Amalendu Prakash Ranjan, Anindita Mukerjee, Jamboor K. Vishwanatha, Lawrence Helson
  • SOLID IN OIL/WATER EMULSION-DIFFUSION-EVAPORATION FORMULATION FOR PREPARING CURCUMIN-LOADED PLGA NANOPARTICLES
    Publication number: 20100290982
    Abstract: The present invention includes compositions and methods of making an activated polymeric nanoparticle for targeted drug delivery that includes a biocompatible polymer and an amphiphilic stabilizing agent non-covalently associated with a spacer compound that includes at least one electrophile that selectively reacts with any nucleophilic on a targeting agent and places the targeting agent on the exterior surface of a biodegradable nanoparticle, wherein an active agent is encapsulated in or about the nanoparticle.
    Type: Application
    Filed: April 23, 2010
    Publication date: November 18, 2010
    Applicant: University of North Texas Health Science Center at Fort Worth
    Inventors: Amalendu Prakash Ranjan, Anindita Mukerjee, Jamboor K. Vishwanatha